The price of a stock is the truest depiction of a company's value and what the market anticipates about its performance. A stock's market value is critical, but the process is plagued with uncertainty, leading to investor skepticism. However, in today's economic environment, investors may learn a lot about the market expectations of their target stocks by looking at stock's performance and important indicators. Comparing their expectations to the market could help investors estimate their prospective return.
Period
High
Low
Performance
1 Week1 MonthQuarterHalf Year1 YearYTD23.0123.229.8229.8229.8223.220.3715.513.578.617.4815.5-5.87%+24.02%+46.18%+107.98%+78.29%+24.02%RIGL has a current P/E ratio of 95.14
The RIGL stock has a trailing twelve month price-to sales (P/S) ratio of 2.35 while its price-to-book (P/B) value is -25.23.
RIGL's price-to-free-cashflow (P/FCF) ratio is 34.84, an indicator that is currently being trending upward.
Based on RIGL's recent bid, its distance from 20 days simple moving average is 5.34%. It is 0.55% apart from 50 days simple moving average, and it is 43.43% apart from 200 days simple moving average.
The 52-week high for RIGL is $29.82 which is -30.05% away from the current price level whereas the distance of that from the 52-week low of $7.48 stands at 178.72%.
The performance of RIGL stock was not encouraging with most of its significant price indicators in green. Rigel Pharmaceuticals, Inc.(NASDAQ: RIGL) shares have moved downward -1.42% or -$0.30 in the latest trading session and have gained 24.02% year-to-date (YTD). The stock has gained nearly 78.29% over the past year. After moving 46.18% over the trailing 3-month period, the stock is 107.98% higher in the 6-month period. Looking at its performance over the shorter term, it'slost -5.87% a week and 24.02% a month.
The current 14-day RSI for RIGL stock is 53.78. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.
ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Rigel Pharmaceuticals, Inc. (RIGL) has a 14-day ATR of 1.35.
After closing at $21.16 with 17.62M of its shares outstanding, the current enterprise value of RIGL is roughly 225.09M.
Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is up 78.29% when it comes to the percentage price change over the past 52-weeks. The percentage price change came more than that of broader S&P 500 index that came at a rise of 21.77%. RIGL stock price is also up 24.02% on its value in year-to-date trading.
The number outstanding shares of RIGL is 17.62M, and of these 98.01% shares are freely available for trading. On average, RIGL stock has traded 200.16K shares per day for the past 10 days. A total of 127.31K shares changed hands during the last trading session with the average session volume of 287.17K shares.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com